IBA Molecular and Mallinckrodt Nuclear Medicine LLC to create a new, world-class radiopharmaceutical company: Curium
7 April 2017
"Today, I am excited to announce the uniting of IBA Molecular and Mallinckrodt Nuclear Medicine LLC to create Curium - a world-class provider in nuclear imaging,&q